New dialysis device for kids: a safer way to clean blood?
NCT ID NCT06603324
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tests a special dialysis machine, the MultiFiltratePRO, in children with acute kidney failure. The goal is to see if it can deliver at least 80% of the prescribed treatment within 72 hours while being safe. About 43 children weighing between 8 and 40 kilograms will be treated for up to 10 days, and doctors will watch for side effects like low blood pressure or electrolyte problems.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
MultiFiltratePRO device for continuous venovenous hemodiafiltration (CVVHD)
What this could lead to
If successful, this could confirm that the MultiFiltratePRO device safely and effectively delivers dialysis to children, improving care for pediatric kidney failure.
What could go wrong
This is a small, early-stage study with only 43 participants, so results may not apply to all children. Risks include side effects like low blood pressure or electrolyte imbalances.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RENAL FAILURE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Universitätsklinikum Frankfurt
Frankfurt, 60590, Germany
Contact Email: •••••@•••••